Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer.
about
Chimeric Antigen Receptors Modified T-Cells for Cancer TherapyCAR T Cell Therapy: A Game Changer in Cancer TreatmentChimeric antigen receptor therapy for cancerImmunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapiesEngineered T cells for cancer treatmentThe basic principles of chimeric antigen receptor design.Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.Genetically engineered T cells for the treatment of cancer.Influence of untranslated regions on retroviral mRNA transfer and expressionHuman adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT CellsNucleofection induces transient eIF2α phosphorylation by GCN2 and PERK.The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic MalignanciesPotential limitations of the NSG humanized mouse as a model system to optimize engineered human T cell therapy for cancer.CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside.Genetic redirection of T cells for cancer therapy.Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.CAR T cells: driving the road from the laboratory to the clinic.Adoptive immunotherapy for cancer or viruses.Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model.From humble beginnings to success in the clinic: Chimeric antigen receptor-modified T-cells and implications for immunotherapy.Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes.Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone.Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cells.Selective immunotargeting of diabetogenic CD4 T cells by genetically redirected T cells.A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor.Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them.T-cell receptor transfer into human T cells with ecotropic retroviral vectors.Treatment of advanced leukemia in mice with mRNA engineered T cells.T cells engineered with a cytomegalovirus-specific chimeric immunoreceptor.Therapeutic T cell engineering.RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.Nature of tumor control by permanently and transiently modified GD2 chimeric antigen receptor T cells in xenograft models of neuroblastoma.T Cell Receptor Profiling in Type 1 Diabetes.Practical considerations for chimeric antigen receptor design and delivery.Strong and sustained effector function of memory- versus naïve-derived T cells upon T-cell receptor RNA transfer: implications for cellular therapy.Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes.Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.
P2860
Q26773309-4851C03D-566C-465F-9CD0-3B63DDF2A233Q26822769-F5FF45CE-40DB-4775-94EB-439FD4D1B2E7Q27013599-BC3A20EA-294E-4D71-BD05-A733A18B4C3DQ27027243-AC8983C5-67D4-447E-A383-FD5869EB4C87Q33578792-E141DF83-83B3-4A7D-AEBF-FA80F489218FQ34036213-EBE7CB8B-56F9-4DA5-AD4B-D3FA2E4DCACDQ34166288-4502C3A1-EF2D-4C89-AB48-BD92EB8E2257Q34645898-C9F1217A-8C9B-4C35-88E6-252E4CF1E4D7Q34668961-91C7C7DC-32AE-4DA1-A7D9-DC533BB0FF89Q35308252-1CFE58A4-5CA6-48AC-BA7E-8FF523909EDEQ35677421-D9FA3211-B224-4F4C-8F54-3858AD083202Q35936953-8A7EEA23-D7D5-4458-81AA-090C4CE157A0Q36547199-306E66A7-AA0B-4041-AE63-4D47B725566CQ37233539-ECF99802-AD54-4DD8-8DC6-9CE4557A4573Q37559401-7BF2B119-3900-4A31-8599-A32CBCFBEC13Q37697337-A1FC5BBC-D371-46EC-8AD4-EC2830214FF8Q37751873-41136CEC-C59E-49E0-8CBE-75354BC9BCAEQ38170499-FE2FDF83-46B8-4CC7-BDCE-66D75ABBBAD4Q38178359-2013CF54-DB2A-45F8-8A91-2F9D22D07D3FQ38445486-F8D3558E-35FF-4907-A12E-AD552665AB12Q38468283-976499CB-7DCF-44DF-AD9F-E46DB0140C9FQ38525034-365EF1B6-854E-49C5-B223-2F6C2C9DE6EFQ38720152-0765B48B-D9C6-406F-B1AB-E1B0D168DD2AQ38769271-806E1569-24E0-4369-8CD7-46B683EDAF7EQ38823747-4105134B-FCE6-4007-8BA3-28BF1381A6EDQ38849182-32E8D049-7844-43F4-B657-F6F2991422A9Q38983184-B19E2722-C0A0-4E7C-B5A4-61F95E45A694Q38983814-8146E719-8148-4CA4-B946-ABF6E644C4DAQ38987239-C0112297-A6E2-4239-BF31-B438BC299CE0Q39008906-B03664AD-13FF-4C53-85E7-307E6E67645CQ39784230-81350257-1DF8-401A-9888-DCF438B6F079Q39898534-C900C76F-53B2-4A7F-9EAC-FAD3DD5D465AQ40199809-B44EF3AB-38AC-4608-9120-10F0381B3FA3Q41450925-5F2EC10E-7AE3-42B3-BA13-A1211BFA05A2Q41613624-94F01DEE-109C-4331-99A0-7F69E8672440Q42374922-93507C5D-C404-4F60-BD9B-CACF4A4C61C1Q45868559-3E0B4EF1-A50D-4061-9593-AB405D94B29BQ46157495-9BA0B482-25A9-48D2-99E9-AA2DEE45BE43Q46453590-8FCC117B-F866-4791-958C-DDB57988FD25Q50035982-9D1C8ABD-639D-4DDC-AB31-C31D2A836EF2
P2860
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Transfer of mRNA encoding reco ...... ptive immunotherapy of cancer.
@en
Transfer of mRNA encoding reco ...... ptive immunotherapy of cancer.
@nl
type
label
Transfer of mRNA encoding reco ...... ptive immunotherapy of cancer.
@en
Transfer of mRNA encoding reco ...... ptive immunotherapy of cancer.
@nl
prefLabel
Transfer of mRNA encoding reco ...... ptive immunotherapy of cancer.
@en
Transfer of mRNA encoding reco ...... ptive immunotherapy of cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Transfer of mRNA encoding reco ...... optive immunotherapy of cancer
@en
P2093
K Birkholz
P2860
P2888
P304
P356
10.1038/GT.2008.189
P577
2009-01-22T00:00:00Z
P5875
P6179
1023978429